1.

Which peptide for the treatment of Alzheimer’s disease was approved by the government for phase I clinical trial?(a) Ab(b) Ab43(c) Aβ42(d) Aβ43I had been asked this question at a job interview.My question is based upon Chemical Basis of Life topic in division Chemical Basis of Life of Cell Biology

Answer»

The correct option is (c) Aβ42

To elaborate: Researchers at the Elan PHARMACEUTICALS PUBLISHED some interesting findings in which they used the Amyloid-β-42 peptide to IMMUNIZE mice and saw the mitigation in symptoms of AD.



Discussion

No Comment Found

Related InterviewSolutions